The Global Alanyl-Glutamine Market is valued at approximately USD 158.3 million in 2025 and is projected to grow at a CAGR of 6.12% to reach approximately USD 226.1 million by 2031 (forecast period 2026-2031, base year 2025). The market is segmented by type into 0.99 Purity (Injection-Grade), 0.985 Purity (Standard Pharmaceutical-Grade), Other/Lower-Purity Grades; and by application into Pharmaceutical / Clinical & Parenteral Nutrition, Cell Culture / Biopharmaceutical Manufacturing, Food / Sports & Functional Nutrition, Other (Research, Animal Nutrition). Regional value shares in 2025: North America 43.7%, Europe 31.1%, Asia Pacific 20.0%, Latin America 3.2%, Middle East & Africa 2.0%.
The report provides market sizing in value across type, application, regional and country segments through 2031, a competitive landscape with company-level profiles covering financial performance, business strategy and SWOT analysis, and strategic implications for each profiled company.
The report profiles 6 companies including Fresenius Kabi, Ajinomoto, Kyowa Hakko Bio, Evonik, Jiangsu Chengxin Pharmaceutical, Xi, and is intended for corporate strategy, investment, M&A and procurement teams, with Porter's Five Forces, PESTLE and SWOT analyses and a 2031 outlook.
The report provides market sizing in value across type, application, regional and country segments through 2031, a competitive landscape with company-level profiles covering financial performance, business strategy and SWOT analysis, and strategic implications for each profiled company.
The report profiles 6 companies including Fresenius Kabi, Ajinomoto, Kyowa Hakko Bio, Evonik, Jiangsu Chengxin Pharmaceutical, Xi, and is intended for corporate strategy, investment, M&A and procurement teams, with Porter's Five Forces, PESTLE and SWOT analyses and a 2031 outlook.
Table of Contents
1. Executive Summary2. Industry Overview & Forecast
3. Market Segmentation by Type
4. Market Segmentation by Application
5. Regional Market Forecast
6. Country-Level Market Forecast
7. Growth Drivers & Inhibitors
8. Key Company Profiles (Fresenius Kabi, Ajinomoto, Kyowa Hakko Bio, Evonik, Jiangsu Chengxin Pharmaceutical, Xi)
9. Competitive Landscape
10. Porter's Five Forces Analysis
11. PESTLE Analysis
12. SWOT Analysis
13. Future Trends & Outlook
Companies Mentioned
- Fresenius Kabi
- Ajinomoto
- Kyowa Hakko Bio
- Evonik
- Jiangsu Chengxin Pharmaceutical
- Xi
